Related Experiment Video
Updated: Feb 6, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Continuous hemofiltration improves the prognosis of bacterial sepsis complicated by liver dysfunction in children
Yun Cui1,2, Xi Xiong1,2, Fei Wang1,2
1Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Putuo District, Shanghai, 200062, China.
Insights
Continuous hemofiltration significantly reduces mortality in pediatric sepsis patients with liver dysfunction. This treatment lowers key biomarkers like total bilirubin and inflammatory cytokines, improving patient outcomes.
Area of Science:
- Pediatric Critical Care Medicine
- Sepsis Pathophysiology
- Renal Replacement Therapy
Background:
- Liver dysfunction is a critical factor impacting sepsis patient prognosis.
- Bacterial sepsis with concurrent liver dysfunction presents a significant clinical challenge.
Purpose of the Study:
- To assess the efficacy of continuous hemofiltration (CHF) in pediatric patients with bacterial sepsis and liver dysfunction.
- To evaluate the impact of CHF on mortality and key biochemical markers.
Main Methods:
- Retrospective analysis of 27 pediatric cases of bacterial sepsis with liver dysfunction.
- Comparison between a continuous hemofiltration group (n=16) and a conventional management group (n=11).
Main Results:
- Continuous hemofiltration significantly reduced 28-day mortality (31.3% vs. 72.7%) and pediatric intensive care unit (PICU) length of stay.
- CHF initiation occurred at a median of 22.06 ± 17.68 hours post-PICU admission, with a median duration of 48 hours.
- Significant decreases in total bilirubin, direct bilirubin, total bile acids, ammonia, lactate, TNF-α, and IL-6 were observed after 72 hours of CHF.
Conclusions:
- Continuous hemofiltration is an effective intervention for pediatric bacterial sepsis with liver dysfunction.
- CHF treatment is independently associated with improved 28-day mortality in this patient population.
- CHF effectively reduces key indicators of liver injury and systemic inflammation.
Background:
Liver dysfunction is an independent risk factor for poor prognosis of patients with sepsis. The aim of this study is to evaluate the effects of continuous hemofiltration in patients with bacterial sepsis complicated by liver dysfunction.
Methods:
We retrospectively analyzed the medical records of 27 cases of bacterial sepsis with liver dysfunction admitted to pediatric intensive care unit (PICU) of Shanghai Children's Hospital between January 2013 and December 2016.
Results:
28-day mortality and length of PICU stay were significantly reduced in the continuous hemofiltration group (n = 16) compared with the conventional management group (n = 11) (31.3% vs. 72.7%, 9 [4-23] vs. 14 [4-36], respectively, both P < 0.05). The interval time between PICU admission and continuous hemofiltration initiation was (22.06 ± 17.68) h, and the median time of continuous hemofiltration duration was 48 h (31-70 h). After 72 h hemofiltration, the levels of total bilirubin (TBIL), direct bilirubin (DBIL), total bile acids (TBA), ammonia, lactate (Lac), TNF-α and IL-6 were significantly decreased in the continuous hemofiltration group. Moreover, multivariate logistic regression analysis indicated that continuous hemofiltration treatment and the TBIL level were independently associated with 28-day mortality of patients with bacterial sepsis complicated by liver dysfunction.
Conclusions:
Continuous hemofiltration significantly decreases the serum levels of TBIL, DBIL, TBA, Lac, ammonia, TNF-α, IL-6, and improves 28-day mortality of patients with bacterial sepsis complicated by liver dysfunction.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:39Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemodialysis II: Procedure and Complications
Pneumonia III: Complications and Assessment
Diabetes: Symptoms, Diagnosis, and Complications
Asthma-III: Symptoms and Complications
Classification of Asthma
Continuing Care